Cimmino F, Montella A, Tirelli M, Avitabile M, Lasorsa V, Visconte F
Cancer Cell Int. 2022; 22(1):174.
PMID: 35488346
PMC: 9052553.
DOI: 10.1186/s12935-022-02587-x.
Herranz-Montoya I, Park S, Djouder N
iScience. 2021; 24(11):103273.
PMID: 34761191
PMC: 8567396.
DOI: 10.1016/j.isci.2021.103273.
Mo S, Zhao H, Tian Y, Zhao H
Cancer Manag Res. 2020; 12:8847-8856.
PMID: 33061580
PMC: 7520118.
DOI: 10.2147/CMAR.S270237.
Cockova Z, Ujcikova H, Telensky P, Novotny J
J Biosci. 2019; 44(4).
PMID: 31502566
Murillo J, Goto-Silva L, Sanchez A, Nogueira F, Domont G, Junqueira M
EuPA Open Proteom. 2018; 16:1-11.
PMID: 29900121
PMC: 5965715.
DOI: 10.1016/j.euprot.2017.06.001.
Association between Gene Polymorphisms and Neuroblastoma Risk in Chinese Children: A Two-Center Case-Control Study.
Wu Q, Zhuo Z, Zeng J, Zhang J, Zhu J, Zou Y
J Cancer. 2018; 9(3):535-539.
PMID: 29483959
PMC: 5820921.
DOI: 10.7150/jca.22681.
PFDN1, an indicator for colorectal cancer prognosis, enhances tumor cell proliferation and motility through cytoskeletal reorganization.
Wang P, Zhao J, Yang X, Guan S, Feng H, Han D
Med Oncol. 2015; 32(12):264.
PMID: 26553318
DOI: 10.1007/s12032-015-0710-z.
Probing differentiation in cancer cell lines by single-cell micro-Raman spectroscopy.
Barkur S, Bankapur A, Pradhan M, Chidangil S, Mathur D, Ladiwala U
J Biomed Opt. 2015; 20(8):85001.
PMID: 26244913
DOI: 10.1117/1.JBO.20.8.085001.
Common genetic variants in NEFL influence gene expression and neuroblastoma risk.
Capasso M, Diskin S, Cimmino F, Acierno G, Totaro F, Petrosino G
Cancer Res. 2014; 74(23):6913-24.
PMID: 25312269
PMC: 4253722.
DOI: 10.1158/0008-5472.CAN-14-0431.
Chaperonin CCT-mediated AIB1 folding promotes the growth of ERα-positive breast cancer cells on hard substrates.
Chen L, Zhang Z, Qiu J, Zhang L, Luo X, Jang J
PLoS One. 2014; 9(5):e96085.
PMID: 24788909
PMC: 4006900.
DOI: 10.1371/journal.pone.0096085.
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells.
Franci G, Casalino L, Petraglia F, Miceli M, Menafra R, Radic B
Biol Open. 2013; 2(10):1070-7.
PMID: 24167717
PMC: 3798190.
DOI: 10.1242/bio.20135587.
Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA.
Lopez V, Gonzalez-Peramato P, Suela J, Serrano A, Algaba F, Cigudosa J
J Transl Med. 2013; 11:182.
PMID: 23914742
PMC: 3750577.
DOI: 10.1186/1479-5876-11-182.
Application of proteomics to soft tissue sarcomas.
Kondo T, Kubota D, Kawai A
Int J Proteomics. 2012; 2012:876401.
PMID: 22778956
PMC: 3388341.
DOI: 10.1155/2012/876401.
Identification of phosphoproteins as possible differentiation markers in all-trans-retinoic acid-treated neuroblastoma cells.
Mandili G, Marini C, Carta F, Zanini C, Prato M, Khadjavi A
PLoS One. 2011; 6(5):e18254.
PMID: 21573212
PMC: 3088664.
DOI: 10.1371/journal.pone.0018254.
Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness.
Spano D, Russo R, Di Maso V, Rosso N, Terracciano L, Roncalli M
Mol Med. 2010; 16(3-4):102-15.
PMID: 20200618
PMC: 2829614.
DOI: 10.2119/molmed.2009.00119.
Neurobiological applications of small molecule screening.
Bauer A, Stockwell B
Chem Rev. 2008; 108(5):1774-86.
PMID: 18447397
PMC: 2712879.
DOI: 10.1021/cr0782372.
Proteomic identification of heat shock protein 27 as a differentiation and prognostic marker in neuroblastoma but not in Ewing's sarcoma.
Zanini C, Pulera F, Carta F, Giribaldi G, Mandili G, Maule M
Virchows Arch. 2007; 452(2):157-67.
PMID: 18066588
DOI: 10.1007/s00428-007-0549-6.
